Context: Primary aldosteronism (PA) in the elderly has increased in importance in association with population aging.
Patients and Methods: Using a database of patients with PA who underwent adrenal venous sampling (AVS), we compared elderly patients ($65 years old) with nonelderly patients (,65 years old) in terms of characteristics, subtype classification in ACTH-stimulated AVS, and outcomes after adrenalectomy.
Results:
The elderly group had a higher prevalence of comorbidities than the nonelderly group. The proportion of the unilateral subtype [defined as a lateralization index (LI) .4] was comparable between the age groups. In patients who received adrenalectomy, biochemical cure was comparable between the groups, whereas persistent hypertension was more common in the elderly group. The prevalences of hyperkalemia and renal impairment (chronic kidney disease stage 3b or higher) were higher in the elderly group. Multiple regression analysis showed that the duration of hypertension predicted persistent hypertension and hyperkalemia and that preoperative estimated glomerular filtration rate predicted renal impairment in the elderly group. LI .4 in AVS was an independent predictor of biochemical cure after adrenalectomy in the elderly group but not in the nonelderly group. Age was negatively associated with biochemical cure in patients with LI #4.
Conclusion: Adrenalectomy contributes to biochemical improvement in elderly patients if determined in accordance with AVS. The treatment strategy should be determined considering the high postoperative incidence of persistent hypertension and hyperkalemia in elderly patients with a long history of hypertension or renal impairment in those with reduced renal function. (J Clin Endocrinol Metab 103: 3620-3629, 2018) P rimary aldosteronism (PA) is the leading cause of secondary hypertension. PA affects 5% to 15% of the hypertensive population (1) (2) (3) (4) (5) . Excessive aldosterone release in patients with PA not only elevates blood pressure (BP) but also induces several complications, including congestive heart failure, coronary artery disease, chronic kidney disease (CKD), and metabolic syndrome (6) (7) (8) . As a result, PA is associated with a poorer prognosis than essential hypertension (9) (10) (11) (12) . Therefore, the early diagnosis and specific treatment of PA are of particular importance.
Although PA is highly prevalent in the middle-aged population, recent population aging in developed countries has increased the numbers of elderly patients with PA. However, several factors could interfere with a correct diagnosis and effective treatment of PA in the elderly. First, because the prevalence of essential hypertension dramatically increases with age, the percentage of PA in the elderly population with hypertension may be much smaller than in the nonelderly population with hypertension. Therefore, selection of elderly patients to screen for PA is difficult, and many elderly patients with PA might be treated without an appropriate diagnosis. Second, physiological changes in the profile of circulating hormones due to aging could affect diagnostic procedures for PA. The aldosterone/renin ratio (ARR), which is widely used for initial PA screening, increases with age in the general hypertensive population and in patients with essential hypertension (13) (14) (15) . Nanba et al. (16) recently reported that aging is associated with increased autonomous aldosterone production by aldosteroneproducing cell clusters in normal adrenal glands. This effect might increase false positive results in the screening test and even in the confirmatory tests for PA. Third, the pathophysiological basis of PA in the elderly is largely unknown. In most cases, PA is caused by a unilateral aldosterone-producing adenoma or by bilateral hyperplasia (1). It is crucial to distinguish the unilateral and bilateral subtypes by adrenal venous sampling (AVS) and adrenal CT because the former is treated by adrenalectomy and the latter is treated by mineralocorticoid receptor antagonists (MRAs) (1, 17, 18) . Conversely, the clinical significance of AVS depends on its ability to effectively identify unilateral adenomas. However, there is little bibliographic information about AVS in the elderly, and the subtype distribution of PA in the elderly remains unknown. Furthermore, knowledge about outcomes after adrenalectomy in elderly patients with PA remains largely undetermined. Because elderly patients with PA tend to have multiple comorbidities with reduced organ reserve, the benefits and risks of adrenalectomy in the elderly must be evaluated separately from those in the nonelderly. Considering these specific features of PA in the elderly, new guidelines are needed to diagnose and treat elderly patients with PA. To provide evidence that could contribute to PA guidelines in the elderly, we analyzed a large database of patients with PA who underwent AVS in a multicenter collaborative study in Japan and characterized elderly patients with PA compared with nonelderly patients.
Method

Study population
This study was conducted via a retrospective analysis of a multicenter collaborative study involving 28 referral centers in Japan [Japan Primary Aldosteronism Study (JPAS)]. The JPAS database consists of clinical and laboratory data for patients with PA who underwent AVS, as described previously (19, 20) .
The analysis in the current study was performed with patients who were successfully classified into subtypes by AVS. Of the 2625 patients enrolled in the JPAS by May 2017, 496 and 227 patients were excluded because of insufficient data and unsuccessful cannulation in AVS, respectively. In total, 1902 patients were subjected to the analysis in the current study (Supplemental Fig. 1 ).
Analysis of baseline clinical and laboratory data
Clinical and laboratory data were extracted from the medical records of each referral center. Office BP in the seated position was obtained from medical records at the time of diagnosis. Body mass index [BMI (in kg/m 2 )] was calculated at the first visit. The estimated glomerular filtration rate (eGFR) was calculated with the Japanese GFR equation based on serum creatinine, sex, and age. Plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were measured with commercially available kits. PAC was determined with a radioimmunoassay (SPAC-S Aldosterone kits, Fuji Rebio, Co., Ltd., Tokyo, Japan) in all centers. The reference range of PAC in the supine position was 3.0 to 15.9 ng/dL. PRA was measured with an RIA or enzyme immunoassay. The reference range of PRA in the supine position was 0.3 to 2.9 ng/mL/h (PRA-FR RIA kits, Fuji Rebio, Co., Ltd.) in 16 centers, 0.2 to 2.3 ng/mL/h (PRA enzyme immunoassay kits, Yamasa, Co., Ltd., Choshi, Japan) in eight centers, and 0.2 to 2.7 ng/mL/h (PRA RIA kits, Yamasa, Co., Ltd.) in four centers. The plasma active renin concentration (ARC) was measured with an immunoradiometric assay (Renin IRMA-FR, Fuji Rebio, Co., Ltd.) in one center. The reference range of ARC in the supine positon was 2.5 to 21.4 pg/mL. The ARC value was multiplied by 0.2 for conversion to PRA. Hypokalemia was defined as a serum potassium concentration ,3.5 mEq/L or the use of a potassium supplement. Hyperkalemia was defined as a serum potassium concentration .5 mEq/L. A space-occupying lesion $10 mm within the adrenal glands on CT was defined as an adrenal mass according to previous studies (21) . The duration of hypertension was obtained from medical records. A history of myocardial infarction was confirmed by a cardiologist, cerebral hemorrhage and cerebral infarction were confirmed by a neurologist, and congestive heart failure that necessitated hospitalization was confirmed from the medical records at diagnosis. Diabetes and dyslipidemia were determined if the patient matched the criteria or underwent medical treatment of either disorder.
Analysis of AVS data
We retrospectively classified subtypes in patients who underwent AVS with ACTH (cosyntropin) stimulation, the procedures for which have been described (22) . Unsuccessful cannulation was indicated by a selectivity index ,5. The lateralization index (LI) was calculated by dividing the aldosterone/cortisol ratio on the dominant side by that on the nondominant side. Contralateral suppression was defined as the aldosterone/ cortisol ratio from the nondominant adrenal vein divided by that from the inferior vena cava ,1.
Clinical outcome after adrenalectomy
Because of the retrospective nature of the current study, the indication of adrenalectomy in each case was determined by the physicians in each center. To analyze short-term clinical outcomes after adrenalectomy, clinical and laboratory data from an outpatient visit 6 months after the operation were extracted from medical records. Data from an outpatient visit at 12 months were used if data from a 6-month visit were absent. According to a recent study, complete biochemical success was defined as the normalization of ARR (,200) with the absence of hypokalemia (23) . Complete clinical success was defined as normal BP (,140/90 mm Hg) without the aid of antihypertensive medication (23) .
Analysis and statistics
Statistical analyses were performed in JMP 12.0 (SAS Institute Inc., Cary, NC) and SPSS 23.0 (IBM Corporation, Armonk, NY). Differences in parametric and nonparametric variables were assessed with the Student t test and the Mann-Whitney U test, respectively. Differences in two repeated and independent categorical variables were assessed with the McNemar test and x 2 test, respectively. Relationships between parameters were examined with multiple linear regression analyses. In the multiple logistic regression analyses, we prepared several models by the stepwise method by using combinations of parameters as independent variables for the calculation of both regression coefficients (R 2 ) and Akaike information criterion (AIC). Among the candidate models, we selected the best-fit model by using R 2 and the AIC for each dependent variable.
Ethics
This study was conducted according to the guidelines for clinical studies published by the Ministry of Health and Labor, Japan and was approved by the ethics committee of the National Hospital Organization Kyoto Medical Center as the project lead center and by the institutional ethics committees of the participating centers. This observational study was registered at UMIN ID 18756.
Results
Clinical characteristics of PA
Patients with PA in JPAS were divided into two groups according to their age at initial diagnosis: nonelderly (,65 years) and elderly ($65 years) (n = 1691 and 411, respectively). The characteristics of the two groups are summarized in Table 1 . The PA-specific biochemical data showed that although the elderly group had lower PRA and PAC values, the ARR was comparable between the age groups. There was no difference between the groups in the proportion of patients who are hypokalemic who had a serum potassium concentration ,3.5 mEq/L or received potassium supplements. An adrenal mass $10 mm was more frequently detected in CT in the elderly group than in the nonelderly group. Although systolic BP, which was usually measured while the patient was on antihypertensive medications, was comparable between the groups, diastolic BP was significantly lower in the elderly group than in the nonelderly group. The elderly group also had a lower BMI and worse renal function [higher blood urea nitrogen (BUN) and lower eGFR]. Regarding comorbidities, the elderly group more often had a history of myocardial infarction and a history of ischemic stroke, along with longer durations of hypertension and higher prevalences of diabetes and dyslipidemia, compared with the nonelderly group.
Classification of the PA subtypes by ACTH-stimulated AVS
AVS data after ACTH stimulation were analyzed to investigate the influence of aging on PA subtypes. The patients were retrospectively categorized into LI .4, indicating the unilateral subtype, and LI #4 (Supplemental Fig. 1 ) (24) . The proportion of LI .4 was similar between the groups (Table 2) . Contralateral suppression in patients with LI .4, which is reported to correlate with good shortterm clinical and biochemical outcomes after surgery, was similarly and highly common in both age groups (Table 2) (25). The elderly group with LI #4 had a higher incidence of adrenal mass on CT than the nonelderly group ( Table 2) . The proportion of patients who underwent adrenalectomy was~70% in patients with LI .4 and 10% in patients with LI #4 in AVS (Table 2) .
Short-term clinical outcomes of patients after adrenalectomy
Patients with successful AVS who had follow-up examinations, at least partial, at 6 months were analyzed for short-term clinical outcomes (Supplemental Fig. 1 ). The data at baseline and follow-up in the two groups are summarized in Table 3 . Twenty-one percent of the elderly and 23% of the nonelderly had LI #4. Adrenalectomy improved PAspecific biochemical parameters in both groups. PRA increased and PAC and ARR decreased significantly after adrenalectomy. Hypokalemia was rarely observed in both age groups after adrenalectomy (Table 3) . Complete biochemical success, defined as the normalization of ARR with the absence of hypokalemia (23), was observed similarly between the groups (Table 4) . Regarding the effect of adrenalectomy on BP, BP and the number of antihypertensive drugs decreased significantly after adrenalectomy in both groups (Table 3) . Complete clinical success, defined as normal BP (,140/90 mm Hg) without the aid of antihypertensive medication (23), was less common in the elderly group after surgery ( Table 4 ). The withdrawal of antihypertensive drugs after surgery also occurred less often in the elderly group (Table 4) .
Assessment of adverse clinical outcomes after adrenalectomy
Although a significant increase in BUN and a reduction of eGFR after adrenalectomy were observed in both groups, BUN and eGFR were higher and lower in the elderly group at follow-up, respectively (Table 3) . We defined renal impairment as CKD stage 3b or higher (eGFR #45 mL/min/ 1.73 m 2 ), which is associated with an increase in poor cardiovascular and renal outcomes (26) . Although there was no significant difference in the prevalence of the renal impairment between the two groups at baseline, the renal impairment increased more prominently in the elderly group after adrenalectomy (Table 3) . New onset of renal impairment was more common in the elderly group than the nonelderly group after adrenalectomy (Table 4) . Additionally, 18% of the elderly group had hyperkalemia after adrenalectomy, whereas only 6% of the nonelderly group had hyperkalemia (Table 4) . No elderly patient had a serum potassium concentration of $6.0 mEq/L.
Factors associated with the withdrawal of antihypertensive drugs and hyperkalemia after surgery in elderly patients Because we found that elderly patients were unlikely to achieve complete clinical success and to withdraw antihypertensive drugs and were likely to manifest hyperkalemia and renal impairment after adrenalectomy, we aimed to determine the factors predicting these clinical outcomes before surgery. Using a multiple stepwise regression analysis with the independent variables of age, sex, BMI, duration of hypertension, preoperative eGFR, PAC, PRA, and LI .4 on AVS, we found that the duration of hypertension was the only factor that was negatively associated with the withdrawal of antihypertensive drugs and the only factor positively associated with the onset of hyperkalemia after adrenalectomy. No factors predicted complete clinical success (Table 5 ). Preoperative eGFR was the only factor associated with the new onset of renal impairment (Table 5) .
Receiver operating characteristic analysis showed that the best cutoff value of preoperative eGFR to predict renal impairment in the elderly group was 65.4 mL/min/1.73 m 2 , with a sensitivity of 0.94 and a specificity of 0.80 (Supplemental Fig. 2 ).
Factors associated with complete biochemical success after surgery
We found that the rate of complete biochemical success after adrenalectomy was much lower in the elderly group with LI #4 than in that with LI .4 (33% vs 79%, respectively, P = 0.003). In contrast, complete biochemical success similar in patients with LI #4 and LI .4 in the nonelderly group (69% vs 76%, respectively, P = 0.243). We performed multiple regression analyses to identify factors associated with complete biochemical success by using a model including the independent variables of age, sex, BMI, duration of hypertension, adrenal mass on CT, LI .4 on AVS, and ARR at baseline. LI .4 on AVS was the only factor associated with complete biochemical success after surgery in elderly patients (Table 6 ). By contrast, lower age was the only factor associated with complete biochemical success in the nonelderly group (Table 6 ). Finally, we performed multiple regression analyses in patients of all ages stratified by LI .4 and LI #4 on AVS. Lower age was positively associated with complete biochemical success in patients with LI #4, but no association was observed in patients with LI .4 ( Table 6 ).
Discussion
In this study, we analyzed a large database of patients with PA who underwent AVS to characterize elderly patients with defined PA. As expected, we found that elderly patients with PA were more likely to have a history of cardiovascular diseases and reduced renal function accompanied by longer exposure to hypertension than nonelderly patients with PA. Although we did not compare elderly patients with PA with those with essential hypertension, previous studies have suggested that patients with PA have a poorer prognosis than those with essential hypertension (9) (10) (11) (12) . Because the duration of hypertension in patients with PA should be closely associated with the duration of PA, our findings support the importance of PA detection at earlier ages.
We found that patients who underwent adrenalectomy received similar benefits irrespective of their age in terms of improvement in biochemical parameters. The recent consensus proposed the use of new standard outcome criteria for assessing biochemical and clinical success after adrenalectomy (23) . Using the new criteria, we found that rates of complete biochemical success were similar in the nonelderly and elderly groups (23) . By contrast, we found that complete clinical success, which indicates a cure of office hypertension, was less common and occurred in only 20% of elderly patients. Our findings are consistent with the report that younger age is associated with clinical success (23) . We also evaluated the withdrawal of antihypertensive drugs, which is clinically important in elderly patients because white coat hypertension increases with aging. We found that the duration of hypertension until diagnosis of PA, but not age itself, negatively predicts withdrawal of antihypertensives after adrenalectomy in elderly patients. Taken together, adrenalectomy is beneficial in curing PA-related biochemical disorders irrespective of age, but remission of hypertension is less expected in elderly patients, particularly those with a long exposure to hypertension. Nevertheless, adrenalectomy contributed to reduction of antihypertensive medications in elderly patients with the unilateral subtype. In the elderly group, one-third of patients with LI .4 (n = 32) were treated with mineralocorticoid receptor antagonist-based medications instead of adrenalectomy (Supplemental Fig. 1 ). Regarding short-term clinical outcomes, we found a difference between these patients and those with adrenalectomy in the number of antihypertensive drugs (1.6 6 1.2 vs 1.0 6 0.8, P , 0.016) but not in renal function or office BP (data not shown).
Kidney function as estimated by BUN and eGFR decreased shortly after adrenalectomy in both age groups. Not surprisingly, preoperative eGFR was associated with new onset of renal impairment (CKD stage 3b or higher) in elderly patients. In particular, a preoperative eGFR of #65 mL/min/ 1.73 m 2 predicted renal impairment with high sensitivity. Adrenalectomy or spironolactone in patients with PA Biochemical success is defined as normalization of ARR (,200) with the absence of hypokalemia; complete clinical success is defined as BP ,140/90 mm Hg without the aid of antihypertensive medication; hyperkalemia is defined as serum K .5 mEq/L; renal impairment is defined as CKD stage 3b or higher. a Number of patients who had sufficient data for each outcome.
induced the initial decline in creatinine clearance, but the subsequent decline of creatinine clearance was comparable between patients with PA and patients with essential hypertension (27) . A longer observation is necessary to investigate whether the postoperative appearance of renal impairment would lead to progressive renal damage and poor prognosis in elderly patients with PA. Notably, after adrenalectomy, 18% of elderly patients had elevated serum potassium. We also found that a long hypertension history was an independent predictor of hyperkalemia after surgery in elderly patients. Older age and preoperative eGFR are the best independent predictors of postoperative hyperkalemia (28) (29) (30) (31) . In our analysis limited to elderly patients, the association of preoperative eGFR with postoperative hyperkalemia did not reach statistical significance (Table 5 ). We also found that age was not associated with postoperative hyperkalemia in the elderly patients, suggesting that duration of PA history, but not age itself, determines susceptibility to postoperative hyperkalemia. Our findings suggest that serum potassium concentration should be carefully monitored after adrenalectomy, particularly in elderly patients with a long hypertension history. Because of the excellent specificity, LI .4 in ACTHstimulated AVS is the most widely used criterion to determine the unilateral subtype of PA (24) . There was a clear difference in the biochemical outcomes of elderly patients with LI .4 and those with LI #4 in ACTH-stimulated AVS. Multiple regression analysis also indicated that LI .4 in AVS was an independent predictor of complete biochemical success in elderly patients with PA. These results are in contrast to the analysis in the nonelderly, in which lower age, but not LI .4, was associated with complete biochemical success. We also found that higher age was negatively associated with complete biochemical success in patients of all ages with LI #4. Our findings show that it is conceivable that the sensitivity of LI .4 to detect unilateral PA increases with age in ACTH-stimulated AVS. We found that the prevalence of adrenal masses in elderly patients with LI #4 Stepwise method with all relative parameters as independent variables including age, sex, BMI, duration of hypertension, eGFR, PAC, PRA, and LI .4 on AVS. After R 2 and the AIC were calculated for each model combining these independent variables, the best models were chosen for each analysis. Hyperkalemia is defined as serum K .5 mEq/L; renal impairment is defined as CKD stage 3b or higher. Boldface indicates the factor with significant association (P , 0.05). a Number of patients who had sufficient data for each outcome. was higher than in nonelderly patients, suggesting that the prevalence of nonfunctional adenoma increases in the elderly population (Table 2) . A recent randomized study suggested that there is no difference in short-term clinical outcomes between PA treatment based on CT and AVS (32) , whereas other studies have reported a disagreement in subtype diagnosis between CT and AVS (33, 34) . Our findings clearly support the concept that AVS is superior to CT in distinguishing elderly patients with PA who receive benefit from adrenalectomy.
Because we found that adrenalectomy was associated with improved biochemical outcomes but limited improvement in short-term clinical outcomes in elderly patients, our findings are too premature to indicate that the biochemical improvement after adrenalectomy is associated with decreased cardiovascular events and improved mortality. A longer follow-up would be useful to examine whether decreasing the burden of long-standing aldosterone excess at an advanced age can reverse its multiple negative cardiovascular actions beyond BP elevation (35) .
A limitation of this study is that it was a retrospective, multicenter study. Thus, the indications of AVS in an individual patient differ depending on the decisions of the physicians in each center. This point is important in the elderly because old age per se and age-associated comorbidities could influence variability in the therapeutic decisions of physicians. In addition, we cannot draw any conclusions about the usefulness of the LI cutoff of 4 in nonelderly patients, even though there was no difference in biochemical cure after adrenalectomy in patients with LI .4 vs LI #4. In Japan, the LI cutoff of 4 in ACTHstimulated AVS is widely used in routine clinical practice for PA, as supported by the result that 74% of nonelderly and 67% of elderly with LI .4 underwent adrenalectomy, whereas only 11% of nonelderly and 8% of elderly with LI #4 underwent the surgery (Supplemental Fig. 1 ). Physicians are supposed to choose adrenalectomy in patients with LI #4 based on other signs of probable aldosteroneproducing adenoma, such as hypokalemia, contralateral suppression, and adrenal tumor. This practice could have led to the increase in the biochemical cure rate in patients with LI #4. Conversely, it is notable that the biochemical cure rate was very low in elderly patients with LI #4, suggesting that adrenalectomy does not cure PA in most Boldface indicates the factor with significant association (P ,0.05). a Number of patients who had sufficient data for the outcome.
b Odds of the range.
doi: 10.1210/jc.2018-00059 https://academic.oup.com/jcemelderly patients with LI #4 even when chosen under a physician's guidance in clinical practice. The absence of long-term clinical outcomes is another limitation. Additional investigation will be necessary to clarify whether adrenalectomy is beneficial in long-term clinical outcomes in elderly patients with PA. In summary, elderly patients with PA were likely to have a long hypertension history and subsequent cardiovascular comorbidities, highlighting the importance of PA detection at an earlier age. Adrenalectomy was useful in elderly patients in terms of biochemical cure and the reduction of antihypertensive treatment, but remission of hypertension was limited in the population. Caution should be taken in postoperative renal impairment and hyperkalemia in elderly patients. The close association between a long hypertension history and poor clinical outcomes of adrenalectomy, including residual hypertension and hyperkalemia, again emphasizes the importance of early detection and proper treatment of PA. Biochemical cure occurred less often in elderly but not nonelderly patients with LI #4 in AVS, and the defined unilateral subtype with LI .4 strongly predicted biochemical cure in the elderly. These findings suggest that the indication of adrenalectomy should be strictly applied according to the classification of AVS, particularly in the elderly.
